Laboratory tests and measurements in children born small for gestational age (SGA)

Caterina Geremia, Stefano Cianfarani

Research output: Contribution to journalArticle

Abstract

Children born small for gestational age are at high risk of developing insulin resistance, type 2 diabetes, hyperlipidemia, hypertension and cardiovascular disease in adulthood. In addition, approximately 10% of SGA children do not achieve a normal adult height. Studies performed in SGA children to evaluate markers of metabolic disease in prepubertal, pubertal and adolescent subjects, indicate a higher prevalence of subtle endocrine and metabolic abnormalities that may precede the onset of overt disease in adulthood. At present, however, there are no conclusive data supporting the need of systematic close monitoring of GH-IGF, hypothalamus-pituitary-adrenal and hypothalamus-pituitary-gonadal axes, as well as insulin sensitivity, glucose homeostasis, and lipid metabolism. Monitoring of metabolic parameters should probably be reserved to SGA children with genetic predisposition to type 2 diabetes and hyperlipidemia, as early identification of metabolic alterations might prompt effective preventive interventions and, ultimately, reduce cardiovascular risk.

Original languageEnglish
Pages (from-to)113-123
Number of pages11
JournalClinica Chimica Acta
Volume364
Issue number1-2
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Gestational Age
Medical problems
Hyperlipidemias
Insulin
Type 2 Diabetes Mellitus
Hypothalamus
Insulin Resistance
Monitoring
Metabolic Diseases
Genetic Predisposition to Disease
Lipid Metabolism
Glucose
Homeostasis
Cardiovascular Diseases
Hypertension

Keywords

  • Adipocytokines
  • Growth hormone
  • Insulin sensitivity
  • Intrauterine growth retardation (IUGR)
  • Reprogramming
  • Small for gestational age (SGA)

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry

Cite this

Laboratory tests and measurements in children born small for gestational age (SGA). / Geremia, Caterina; Cianfarani, Stefano.

In: Clinica Chimica Acta, Vol. 364, No. 1-2, 02.2006, p. 113-123.

Research output: Contribution to journalArticle

@article{e701998fe6394fbf931c237df1e24740,
title = "Laboratory tests and measurements in children born small for gestational age (SGA)",
abstract = "Children born small for gestational age are at high risk of developing insulin resistance, type 2 diabetes, hyperlipidemia, hypertension and cardiovascular disease in adulthood. In addition, approximately 10{\%} of SGA children do not achieve a normal adult height. Studies performed in SGA children to evaluate markers of metabolic disease in prepubertal, pubertal and adolescent subjects, indicate a higher prevalence of subtle endocrine and metabolic abnormalities that may precede the onset of overt disease in adulthood. At present, however, there are no conclusive data supporting the need of systematic close monitoring of GH-IGF, hypothalamus-pituitary-adrenal and hypothalamus-pituitary-gonadal axes, as well as insulin sensitivity, glucose homeostasis, and lipid metabolism. Monitoring of metabolic parameters should probably be reserved to SGA children with genetic predisposition to type 2 diabetes and hyperlipidemia, as early identification of metabolic alterations might prompt effective preventive interventions and, ultimately, reduce cardiovascular risk.",
keywords = "Adipocytokines, Growth hormone, Insulin sensitivity, Intrauterine growth retardation (IUGR), Reprogramming, Small for gestational age (SGA)",
author = "Caterina Geremia and Stefano Cianfarani",
year = "2006",
month = "2",
doi = "10.1016/j.cca.2005.06.012",
language = "English",
volume = "364",
pages = "113--123",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Laboratory tests and measurements in children born small for gestational age (SGA)

AU - Geremia, Caterina

AU - Cianfarani, Stefano

PY - 2006/2

Y1 - 2006/2

N2 - Children born small for gestational age are at high risk of developing insulin resistance, type 2 diabetes, hyperlipidemia, hypertension and cardiovascular disease in adulthood. In addition, approximately 10% of SGA children do not achieve a normal adult height. Studies performed in SGA children to evaluate markers of metabolic disease in prepubertal, pubertal and adolescent subjects, indicate a higher prevalence of subtle endocrine and metabolic abnormalities that may precede the onset of overt disease in adulthood. At present, however, there are no conclusive data supporting the need of systematic close monitoring of GH-IGF, hypothalamus-pituitary-adrenal and hypothalamus-pituitary-gonadal axes, as well as insulin sensitivity, glucose homeostasis, and lipid metabolism. Monitoring of metabolic parameters should probably be reserved to SGA children with genetic predisposition to type 2 diabetes and hyperlipidemia, as early identification of metabolic alterations might prompt effective preventive interventions and, ultimately, reduce cardiovascular risk.

AB - Children born small for gestational age are at high risk of developing insulin resistance, type 2 diabetes, hyperlipidemia, hypertension and cardiovascular disease in adulthood. In addition, approximately 10% of SGA children do not achieve a normal adult height. Studies performed in SGA children to evaluate markers of metabolic disease in prepubertal, pubertal and adolescent subjects, indicate a higher prevalence of subtle endocrine and metabolic abnormalities that may precede the onset of overt disease in adulthood. At present, however, there are no conclusive data supporting the need of systematic close monitoring of GH-IGF, hypothalamus-pituitary-adrenal and hypothalamus-pituitary-gonadal axes, as well as insulin sensitivity, glucose homeostasis, and lipid metabolism. Monitoring of metabolic parameters should probably be reserved to SGA children with genetic predisposition to type 2 diabetes and hyperlipidemia, as early identification of metabolic alterations might prompt effective preventive interventions and, ultimately, reduce cardiovascular risk.

KW - Adipocytokines

KW - Growth hormone

KW - Insulin sensitivity

KW - Intrauterine growth retardation (IUGR)

KW - Reprogramming

KW - Small for gestational age (SGA)

UR - http://www.scopus.com/inward/record.url?scp=31044456576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31044456576&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2005.06.012

DO - 10.1016/j.cca.2005.06.012

M3 - Article

C2 - 16139827

AN - SCOPUS:31044456576

VL - 364

SP - 113

EP - 123

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -